Press release

Cision PR Newswire1 week ago
0

Noah Holdings Reports Q2 2026 Results: Operating Margin Rises to 34.8%; Institutional Productivity Model Validated, AI-Powered Platform + Licensed Professionals + Ecosystem Partners Architecture Now Replicable
Read More »
Cision PR Newswire1 week ago
0

86% of Hiring Managers Say Personality Can Overcome Skills Gaps, 99% Say It Can Accelerate Careers
Read More »
Cision PR Newswire1 week ago
0

Reklaim Ltd Reports Q2 2026 Results: Revenue Up 103%, Net Income of $723,000
Read More »
Cision PR Newswire1 week ago
0

Bluon brings back best-in-class Live Tech Support for HVAC-R field technicians
Read More »
Cision PR Newswire1 week ago
0

Gladius Securitas Offers Complimentary Red Teaming Assessments
Read More »
Cision PR Newswire1 week ago
0

Jazz Pharmaceuticals Announces Private Offering of $1.0 Billion of Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases
Read More »
Cision PR Newswire1 week ago
0

Enbridge to Extend Permian Export Value Chain with Acquisition of Salt Creek Midstream’s Crude Gathering Business
Read More »
Cision PR Newswire1 week ago
0

HaemaLogiX Announces Major Milestone with First Patient Successfully Dosed with KMCAR™ T-Cell
Read More »
Cision PR Newswire1 week ago
0

American Solar Energy Society Announces 2026 Award Winners and Fellow Inductees
Read More »
Cision PR Newswire1 week ago
0

Vivace Therapeutics Strengthens Leadership Team as It Prepares to Advance VT3989, the First TEAD Inhibitor to enter Phase 3 Clinical Trials, as the Leading Treatment for Mesothelioma
Read More »

Previous page Next page